Pharmacological therapy will lead hyperpigmentation treatment sales through 2036 with 36.9% of the treatment segment in 2026. Drug and cosmetic stores lead the distribution channel with a 42.7% share. The market is projected to reach USD 6.2 million in 2026 and USD 14.7 million by 2036, creating an incremental opportunity of USD 8.5 million.